Published in Biochim Biophys Acta on May 25, 1984
Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy. Arthritis Res Ther (2010) 1.04
Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers. Mol Pharm (2006) 1.03
Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel. J Control Release (2012) 0.99
Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics. J Control Release (2010) 0.97
Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model. Mol Pharm (2010) 0.92
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer (1987) 0.90
Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates. Mol Pharm (2008) 0.89
Macromolecular therapeutics. J Control Release (2014) 0.87
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. Br J Cancer (1988) 0.83
FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy. J Control Release (2015) 0.78
Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate. J Control Release (2016) 0.75
Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J Biol Chem (1987) 4.48
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release (2000) 3.07
An improved method for enzymic determination of glucose in the presence of maltose. Anal Biochem (1969) 2.63
The effect of chemical treatments of albumin and orosomucoid on rate of clearance from the rat bloodstream and rate of pinocytic capture of rat yolk sac cultured in vitro. Biochem J (1977) 2.36
Quantitative studies of pinocytosis. II. Kinetics of protein uptake and digestion by rat yolk sac cultured in vitro. J Cell Biol (1975) 2.20
Digestion of an exogenous protein by rat yolk-sac cultured in vitro. Biochem J (1971) 2.07
General practice computing in Scotland. BMJ (1990) 2.06
Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ (2002) 2.05
Heat shock-induced translational alterations in HeLa cells. Initiation factor modifications and the inhibition of translation. J Biol Chem (1984) 1.99
Identification and quantitation of levels of protein synthesis initiation factors in crude HeLa cell lysates by two-dimensional polyacrylamide gel electrophoresis. J Biol Chem (1983) 1.97
Quantitative studies of pinocytosis. I. Kinetics of uptake of (125I)polyvinylpyrrolidone by rat yolk sac cultured in vitro. J Cell Biol (1975) 1.86
Studies on the permeability of rat liver lysosomes to carbohydrates. Biochem J (1969) 1.85
Regulation of initiation factors during translational repression caused by serum depletion. Covalent modification. J Biol Chem (1985) 1.83
Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 1.78
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry (2011) 1.69
Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res (1998) 1.68
Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs (1999) 1.67
A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses. EMBO J (2000) 1.66
A quantitative study of pinocytosis and intracellular proteolysis in rat peritoneal macrophages. Biochem J (1977) 1.64
Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology (2011) 1.62
Preferential utilization of phosphorylated 40-S ribosomal subunits during initiation complex formation. Eur J Biochem (1982) 1.62
Mechanism of interferon action. Increased phosphorylation of protein synthesis initiation factor eIF-2 alpha in interferon-treated, reovirus-infected mouse L929 fibroblasts in vitro and in vivo. J Biol Chem (1984) 1.61
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res (1987) 1.60
Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry (2003) 1.53
A histochemical and biochemical study of some aspects of placental function in the rat using maternal injection of horseradish peroxidase. J Anat (1967) 1.53
The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures. J Neurol Neurosurg Psychiatry (2005) 1.52
The effect of Trypan Blue, suramin and aurothiomalate on the breakdown of 125 I-labelled albumin within rat liver lysosomes. Biochem J (1971) 1.51
The nucleotide sequence of infectious pancreatic necrosis virus (IPNV) dsRNA segment A reveals one large ORF encoding a precursor polyprotein. Nucleic Acids Res (1986) 1.47
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release (1998) 1.45
The pinocytosis of 125I-labelled poly(vinylpyrrolidone), [14C]sucrose and colloidal [198Au]gold by rat yolk sac cultured in vitro. Biochem J (1977) 1.43
A study of permeability of lysosomes to amino acids and small peptides. Biochem J (1971) 1.42
Lysosomal enzyme inhibition by trypan blue: a theory of teratogenesis. Science (1967) 1.42
Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women. Ann Intern Med (1989) 1.41
Comparison of bimanual examination with ultrasound examination before hysterectomy for uterine leiomyoma. Obstet Gynecol (1998) 1.41
Many universities do teach professionalism. Br J Nurs (2002) 1.39
Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer (2000) 1.34
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release (1998) 1.33
Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care. Ann Rheum Dis (2006) 1.32
Protein digestion in isolated lysosomes inhibited by intralysosomal trypan blue. Science (1969) 1.32
Prevalence of evidence of prior myocardial infarction, hypertension, diabetes and obesity in three neighboring communities in Pennsylvania. Am J Med Sci (1967) 1.31
Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur J Cancer (2001) 1.30
Simple methods for assessing haplotype-environment interactions in case-only and case-control studies. Genet Epidemiol (2007) 1.29
Soluble biomedical polymers. Polim Med (1977) 1.28
Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem Pharmacol (1998) 1.28
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur J Cancer (1995) 1.26
Biochemical and biophysical characterization of the reovirus cell attachment protein sigma 1: evidence that it is a homotrimer. Virology (1991) 1.25
Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. J Biomed Mater Res (1989) 1.24
Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells. J Virol (1985) 1.24
Rapid alterations in initiation rate and recruitment of inactive RNA are temporally correlated with S6 phosphorylation. Eur J Biochem (1982) 1.23
A quantitative study of pinocytosis and lysosome function in experimentally induced lysosomal storage. Biochem J (1976) 1.21
Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption. J Cell Biol (1990) 1.21
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc. J Biol Chem (1995) 1.19
Congenital talipes equinovarus: a review of current management. J Bone Joint Surg Br (2007) 1.18
The cell attachment proteins of type 1 and type 3 reovirus are differentially susceptible to trypsin and chymotrypsin. Virology (1989) 1.16
Protein synthesis eukaryotic initiation factors 4A and 4B are not altered by poliovirus infection of HeLa cells. J Biol Chem (1983) 1.13
Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology (2011) 1.12
Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharm Res (2000) 1.12
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J Control Release (1999) 1.12
Disulphide reduction in lysosomes. The role of cysteine. Biochem J (1986) 1.11
The contribution of selected non-articular conditions to knee pain severity and associated disability in older adults. Osteoarthritis Cartilage (2008) 1.11
Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm (1999) 1.10
Pinocytosis in the rat visceral yolk sac. Effects of temperature, metabolic inhibitors and some other modifiers. Biochim Biophys Acta (1978) 1.09
Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg (2010) 1.08
Cellular transport of lysosomal enzymes: an alternative hypothesis. Biochem J (1977) 1.08
Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings. Biomaterials (1990) 1.07
Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain (2009) 1.06
Assessment of welfare of suckling lambs following intradermal injection of cetrimide as a non-surgical alternative to conventional mulesing. Aust Vet J (2009) 1.06
Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys Acta (1986) 1.06
LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene (2000) 1.06
Effect of the non-steroidal anti-inflammatory drug, carprofen, on weaned sheep following non-surgical mulesing by intradermal injection of cetrimide. Aust Vet J (2009) 1.05
Site-directed mutagenesis of the C-terminal portion of reovirus protein sigma 1: evidence for a conformation-dependent receptor binding domain. Virology (1992) 1.05
Role of thiols in degradation of proteins by cathepsins. Biochem J (1982) 1.05
Cellular uptake and release of two contrasting iron chelators. J Pharm Pharmacol (1999) 1.04
Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim Biophys Acta (1986) 1.04
Membrane economics in endocytic systems. J Theor Biol (1977) 1.03
Expression of a mutant form of Leishmania donovani centrin reduces the growth of the parasite. J Biol Chem (2001) 1.02
Effects of temperature, metabolic inhibitors and some other factors on fluid-phase and adsorptive pinocytosis by rat peritoneal macrophages. Biochem J (1979) 1.02
Evidence for lysosomal reduction of cystine residues. Biochem Biophys Res Commun (1979) 1.02
Rubella virus E2 signal peptide is required for perinuclear localization of capsid protein and virus assembly. J Virol (2001) 1.02
Predicting the course of functional limitation among older adults with knee pain: do local signs, symptoms and radiographs add anything to general indicators? Ann Rheum Dis (2008) 1.02
Phosphorylation of ribosomal protein S6. Relationship to protein synthesis in HeLa cells. Eur J Biochem (1981) 1.01
Novel pH-sensitive hydrogels with adjustable swelling kinetics. Biomaterials (1998) 1.00
Hybrid hydrogels cross-linked by genetically engineered coiled-coil block proteins. Biomacromolecules (2001) 1.00
Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep (1992) 1.00
The role of the visceral yolk sac in mediating protein utilization by rat embryos cultured in vitro. J Embryol Exp Morphol (1981) 1.00
Entamoeba histolytica interactions with polarized human intestinal Caco-2 epithelial cells. Infect Immun (1994) 1.00